Company Filing History:
Years Active: 2013
Title: Jochen Pfeifer: Innovator in Bradykinin B2 Receptor Modulation
Introduction
Jochen Pfeifer is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate the bradykinin B2 receptor. His innovative work has led to the filing of a patent that showcases his expertise and creativity in medicinal chemistry.
Latest Patents
Jochen Pfeifer holds a patent for "8-oxy-quinoline derivatives as bradykinin B2 receptor modulators." This invention relates to a compound of the formula (I) or a pharmacologically acceptable salt, solvate, or hydrate thereof. The compound features a 6-membered heteroaryl structure with 1 to 3 heteroatoms, which are independently selected from nitrogen or oxygen. The other substituents are defined as specified in the claims of the patent. He has 1 patent to his name.
Career Highlights
Throughout his career, Jochen Pfeifer has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Shire Orphan Therapies GmbH and Jerini AG. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Jochen has collaborated with several professionals during his career, including Christoph Gibson and Thomas Tradler. These partnerships have enriched his work and fostered innovation in the development of new therapeutic compounds.
Conclusion
Jochen Pfeifer is a distinguished inventor whose work in bradykinin B2 receptor modulation has made a significant impact in pharmacology. His patent and collaborations reflect his dedication to advancing medical science.